Growth hormone/insulin-like growth factor-1/PTH axis in bone

Journal of Bone and Mineral Research

Volumn 23, Issue 5, 2008, Pages 581-583

  Bikle, Daniel D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; GROWTH HORMONE; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; SODIUM PHOSPHATE COTRANSPORTER; SOMATOMEDIN C;

AUTOCRINE EFFECT; BONE DENSITY; BONE GROWTH; BONE MINERALIZATION; CORTICAL BONE; DUAL ENERGY X RAY ABSORPTIOMETRY; EDITORIAL; GROWTH HORMONE DEFICIENCY; HORMONE RESPONSE; HUMAN; METAPHYSIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PARATHYROID HORMONE RELEASE; POSTMENOPAUSE OSTEOPOROSIS; TIBIA; TRABECULAR BONE;

ABSORPTIOMETRY, PHOTON; ANIMALS; BONE AND BONES; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PARATHYROID HORMONE;

EID: 42449101742     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080111     Document Type: Editorial

References (40)

1. Joseph F, Ahmad A, Ul-Haq M, Durham B, Whittingham P, Fraser W, Vora J 2007 Effects of Growth Hormone Administration on Bone Mineral Metabolism, Parathyroid Hormone Sensitivity and Parathyroid Hormone Secretory Rhythm in Postmenopausal Women with Established Osteoporosis. J Bone Miner Res 23:721-729.
2. Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD 2003 Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. J Clin Endocrinol Metab 88:2860-2868.
3. Wright NM, Papadea N, Wentz B, Hollis B, Willi S, Bell NH 1997 Increased serum 1,25-dihydroxyvitamin D after growth hormone administration is not parathyroid hormone-mediated. Calcif Tissue Int 61:101-103.
4. Cappelli C, Gandossi E, Agosti B, Cerudelli B, Cumetti D, Castellano M, Pirola I, De Martino E, Rosei EA 2004 Long-term treatment of acromegaly with lanreotide: Evidence of increased serum parathormone concentration. Endocr J 51:517-520.
5. Coiro V, Volpi R, Capretti L, Finardi L, Magotti MG, Manfredi G, Chiodera P, Saccani Jotti G 2004 Inhibition of growth hormone secretion in mild primary hyperparathyroidism. Horm Res 62:88-91.
6. Zoidis E, Gosteli-Peter M, Ghirlanda-Keller C, Meinel L, Zapf J, Schmid C 2002 IGF-I and GH stimulate Phex mRNA expression in lungs and bones and 1,25-dihydroxyvitamin D(3) production in hypophysectomized rats. Eur J Endocrinol 146:97-105.
7. Hirschberg R, Adler S 1998 Insulin-like growth factor system and the kidney: Physiology, pathophysiology, and therapeutic implications. Am J Kidney Dis 31:901-919.
8. Jehle AW, Forgo J, Biber J, Lederer E, Krapf R, Murer H 1998 IGF-I and vanadate stimulate Na/Pi-cotransport in OK cells by increasing type II Na/Pi-cotransporter protein stability. Pflugers Arch 437:149-154.
9. Andreassen TT, Oxlund H 2000 The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats. J Bone Miner Res 15:2266-2275.
10. Wang L, Orhii PB, Banu J, Kalu DN 2001 Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats. Bone 28:202-207.
11. Spencer EM, Liu CC, Si EC, Howard GA 1991 In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone 12:21-26.
12. Bagi CM, DeLeon E, Brommage R, Rosen D, Sommer A 1995 Treatment of ovariectomized rats with the complex of rhIGF-I/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck. Calcif Tissue Int 57:40-46.
13. Bagi CM, DeLeon E, Brommage R, Adams S, Rosen D, Sommer A 1995 Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats. Bone 16(4 Suppl):263S-269S.
14. Narusawa K, Nakamura T, Suzuki K, Matsuoka Y, Lee LJ, Tanaka H, Seino Y 1995 The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy. J Bone Miner Res 10:1853-1864.
15. Bravenboer N, Holzmann P, de Boer H, Roos JC, van der Veen EA, Lips P 1997 The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men. J Clin Endocrinol Metab 82:1818-1822.
16. Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A 1996 Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 125:883-890.
17. Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson BA 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81:2865-2873.
18. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76:1344-1348.
19. Kidder LS, Schmidt IU, Evans GL, Turner RT 1997 Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats. Calcif Tissue Int 61:327-335.
20. Andreassen TT, Melsen F, Oxlund H 1996 The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats. J Bone Miner Res 11:1094-1102.
21. Verhaeghe J, van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J, Mosekilde L, Einhorn TA, Bouillon R 1996 Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats. J Bone Miner Res 11:1723-1735.
22. Bikle DD, Harris J, Halloran BP, Currier PA, Tanner S, Morey-Holton E 1995 The molecular response of bone to growth hormone during skeletal unloading: Regional differences. Endocrinology 136:2099-2109.
23. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329.
24. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781.
25. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674-2682.
26. Clemens TL, Chernausek SD 2004 Genetic strategies for elucidating insulin-like growth factor action in bone. Growth Horm IGF Res 14:195-199.
27. Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C, Halloran B 2001 The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 16:2320-2329.
28. Hou P, Sato T, Hofstetter W, Foged NT 1997 Identification and characterization of the insulin-like growth factor I receptor in mature rabbit osteoclasts. J Bone Miner Res 12:534-540.
29. Fiorelli G, Formigli L, Zecchi Orlandini S, Gori F, Falchetti A, Morelli A, Tanini A, Benvenuti S, Brandi ML 1996 Characterization and function of the receptor for IGF-I in human preosteoclastic cells. Bone 18:269-276.
30. Lazowski DA, Fraher LJ, Hodsman A, Steer B, Modrowski D, Han VK 1994 Regional variation of insulin-like growth factor-I gene expression in mature rat bone and cartilage. Bone 15:563-576.
31. Hayden JM, Mohan S, Baylink DJ 1995 The insulin-like growth factor system and the coupling of formation to resorption. Bone 17(2 Suppl):93S-98S.
32. Hill PA, Reynolds JJ, Meikle MC 1995 Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 136:124-131.
33. Rubin J, Ackert-Bicknell CL, Zhu L, Fan X, Murphy TC, Nanes MS, Marcus R, Holloway L, Beamer WG, Rosen CJ 2002 IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo. J Clin Endocrinol Metab 87:4273-4279.
34. Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD 2006 Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21:1350-1358.
35. Watson P, Lazowski D, Han V, Fraher L, Steer B, Hodsman A 1995 Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 16:357-365.
36. Pfeilschifter J, Laukhuf F, Muller-Beckmann B, Blum WF, Pfister T, Ziegler R 1995 Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest 96:767-774.
37. Canalis E, Centrella M, Burch W, McCarthy TL 1989 Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60-65.
38. Linkhart TA, Mohan S 1989 Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 125:1484-1491.
39. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP 2002 Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 17:1570-1578.
40. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL 2002 Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012.